Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Green fabrication and antibacterial evaluation of lysozyme-immobilized cysteine-capped silver nanoparticles.

Preparative biochemistry & biotechnology·2026
Same author

Exploring the Role of MET Gene as a Potential Biomarker and Therapeutic Target in Ampullary Cancer.

Pancreas·2026
Same author

A privacy-preserving cloud storage framework with hybrid encryption, homomorphic keyword search, and blockchain-based integrity verification.

Scientific reports·2026
Same author

Editorial: Transforming vaccine strategies: co-delivery systems for robust immunity and disease control.

Frontiers in immunology·2026
Same author

Role of Notch gene receptors as prognostic biomarkers in colorectal cancer.

Scientific reports·2025
Same author

Molecular interplay of ARID1A in gastrointestinal cancers.

Medical oncology (Northwood, London, England)·2025

Related Experiment Video

Updated: Mar 1, 2026

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K

Nanoparticle-Based Mycosis Vaccine.

Swaleha Zubair1, Asim Azhar2, Nazoora Khan2

  • 1Women's College, Aligarh Muslim University (AMU), Aligarh, Uttar Pradesh, 202002, India.

Methods in Molecular Biology (Clifton, N.J.)
|June 7, 2017
PubMed
Summary

Nano-particulate vaccines offer a promising strategy against emerging infectious diseases, particularly fungal pathogens. This study investigates the effectiveness of nano-sized vaccine delivery systems for enhanced protection.

Keywords:
Antifungal vaccinesCryptococcosisEscheriosomeFibrinFungal infectionsLipid vesiclesLiposomeNanoparticles

More Related Videos

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.3K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.1K

Related Experiment Videos

Last Updated: Mar 1, 2026

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.3K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.1K

Area of Science:

  • Immunology
  • Nanotechnology
  • Infectious Diseases

Background:

  • Vaccine strategies have eradicated many historical diseases.
  • Emerging infectious diseases and immunocompromised states (e.g., post-chemotherapy, organ transplant, HIV) increase susceptibility to opportunistic infections, including fungal pathogens.
  • Novel vaccine delivery systems are needed to address these challenges.

Purpose of the Study:

  • To evaluate the efficacy of a nano-particulate-based subunit vaccine delivery system.
  • To assess the protective potential against fungal pathogens.

Main Methods:

  • Development and characterization of a nano-sized vaccine delivery system.
  • In vivo/in vitro studies to assess immune response and protection against fungal challenge (details not provided in abstract).

Main Results:

  • The nano-sized vaccine delivery system demonstrated effectiveness in providing protection against fungal pathogens (specific outcomes not detailed).
  • Nano-particulate vaccines show potential for managing opportunistic fungal infections.

Conclusions:

  • Nano-particulate-based subunit vaccines represent a viable strategy for combating emerging infectious diseases.
  • This approach holds promise for developing novel prophylactic measures against fungal infections, especially in vulnerable populations.